Product Description
1. Fasoracetam Powder Video-AASraw
2. Raw Fasoracetam Powder Basic Characters
| Name: | Papalina kāmala |
| CAS: | 110958-19-5 |
| Kaulike Molecular: | C14H27N3O2 |
| Kaumaha Molecular: | 158.15 |
| Wahi Manaʻo: | 160-166 ° C |
| Hōʻoia Kōkua: | E kūʻai i ke ana wela aiʻole ka mea hoʻomaʻamaʻa |
| kala like 'ole: | Paleʻeleʻele a'āpana paha |
Heaha is Fasoracetam Powder?
ʻO Fasoracetam kahi nootropic synthetic no ka racetams. Ua hoʻokumu mua kahi hui lāʻau lapaʻau Iapana no ka mālama ʻana i ka dementia vascular, akā ʻo ka nele o ka pono i hoʻōki i kona ulu hou ʻana.
Eia nō naʻe, ua ʻike hou ʻia i loko o nā hoʻokolohua lapaʻau, me ka noiʻi e nānā ana i kona hiki ke mālama i nā maʻi psychiatric like ʻole a me ka hoʻomaikaʻi ʻana i ka ʻike maʻamau.
Na Aevi Genomic Medicine i hoʻomaka i nā hoʻokolohua lapaʻau e noiʻi i ka hopena o kēia lāʻau i ka poʻe ma ka autism spectrum disorder, ka poʻe me ka attention deficit hyperactivity disorder (ADHD), a me ka hopohopo.
Pehea ka hana o Fasoracetam i ka lolo?
Hana ʻo Fasoracetam ma ka launa pū ʻana a me ka hoʻololi ʻana i ʻekolu ʻōnaehana neurochemical koʻikoʻi: nā ʻōnaehana glutamatergic, cholinergic, a me gabaergic.
Hiki i nā mea ʻekolu ke hana i ka mana o ka cognition enhancer me nā pono kūpono e like me ka hoʻomaikaʻi ʻana i ka hana cognitive, hoʻemi ʻia ka noe o ka lolo, a me ka hoʻomaikaʻi ʻana i ka noʻonoʻo.
E like me nā mea nootropic ʻē aʻe, hoʻonui ka fasoracetam i nā pae acetylcholine. Hiki i kēia hana cholinergic ke hoʻonui i ka cognition, ka hoʻomanaʻo, ka nānā ʻana, ke ʻano, ka makaʻala, ka neuroplasticity, a me ka hoʻomanaʻo lōʻihi.
I ka manawa like, ke kāohi nei ia i ka haʻihaʻi ʻana o ka acetylcholine e ka cholinesterase, e hoʻoikaika ana i ka lawe ʻana e nā cholinergic receptors.
ʻO ka neurotransmitter ʻē aʻe e hana ai ʻo ia ka gamma-aminobutyric acid (GABA) ma o ka hoʻoponopono ʻana i nā mea loaʻa GABA (B).
Loaʻa nā mea loaʻa GABA i loko o ka ʻōnaehana nūnū waena a, i ka wā e hoʻāla ʻia ai, e hoʻoulu ai i ka hoʻoneʻe ʻana i ka excitation nui i loko o ka ʻōnaehana nerve waena.
I nā huaʻōlelo ʻē aʻe, hoʻomaha ʻo GABA i nā neurons e hoʻolaha i kahi ʻano o ka mālie a me ka ʻoluʻolu. Eia kekahi, kōkua kēia mau hana i ka GABA e lanakila i ka hopohopo, ka makaʻu, nā maʻi hiamoe, a me ke kaumaha.
ʻO ke kolu o ka mīkini e pili ana i ka ʻōnaehana glutamate. Hoʻololi pū ʻo Fasoracetam i nā mea loaʻa metabotropic glutamate mua, e pili ana i nā hana cognitive, neuroprotection, synaptic plasticity, a me ka hopohopo nui.
Hiki ke hoʻopili ʻia nā imbalances o ka neurotransmitter glutamate imbalances i kekahi mau maʻi noʻonoʻo a me ke kino, me ke kaumaha, ADHD, epilepsy, a me ka maʻi Alzheimer, e inoa i kekahi.
ka Nā pōmaikaʻi o Fasoracetam
Hiki i ka maikaʻi o ka hoʻomanaʻo a me kaʻike nui
I ka hoʻāʻo ʻana i nā holoholona, ua pale a hōʻemi ʻia ka fasoracetam i ka amnesia a me ka poina.
ʻOiai ʻaʻohe ʻikepili i loaʻa i ka lehulehu e pili ana i nā hoʻokolohua like i nā kumuhana kanaka, ʻōlelo nā mea hoʻohana he nui ka hoʻomaikaʻi ʻana i ka hoʻomanaʻo i ka wā e lawe ai.
E like me nā racetam nootropics, hoʻonui ka fasoracetam i ka nui o ka acetylcholine, ka neurotransmitter kuleana nui no ka hoʻomanaʻo, aʻo, a me ka cognition.
Hiki ke hoʻoulu i nā pōpilikia a me ke kaumaha
Hiki i ka Fasoracetam ke hoʻomaikaʻi i ke ʻano, hoʻemi i ka hopohopo, a hoʻokiʻekiʻe i ke kaumaha ma o ka hana ʻana ma luna o ʻelua mau mea ikaika loa o ka lolo, ka glutamate a me ka gamma-aminobutyric acid (GABA).
Ma ka manawa like e hoʻoponopono ai i ka GABA, kahi neurotransmitter inhibitory, a me ke kāohi ʻana i ka hana nui o ka excitatory neurotransmitter glutamate, hāʻawi ʻo fasoracetam i nā mea hoʻohana e wehewehe ai i ka manaʻo ʻoluʻolu, ʻaʻohe jittery o ka hoʻomaikaʻi ʻana i ke ʻano, hoʻomaha, a me ka mālie.
ʻAʻohe haʻawina i loaʻa i ka lehulehu e pili ana i ka hopena o ka fasoracetam i ke ʻano, hopohopo, a i ʻole ke kaumaha i loko o ke kanaka, akā nui nā mea hoʻohana e hōʻike nei ua ʻoi aku ka mālie, ka hopohopo, a me ke kaumaha i ka wā e lawe ai.
Loaʻa iā ADHD Treatment
ʻO kekahi o nā haʻawina kanaka i loaʻa i ka lehulehu ma ka fasoracetam e hōʻike ana he hiki ke mālama ʻia no ADHD
ʻO ke aʻoʻana, kahi i pili i nā kumuhana 30 ma waena o nā makahiki o 12 a me 17, ua ho'āʻo i ka pono o ka fasoracetam i ka mālamaʻana i ka ADHD ma waena o nā'ōpio i hōʻike i kahi hoʻololi kūikawā i ka pūnaewele gene glutamatergic. Hoʻopili ikaika ʻia kēia hoʻololi me ADHD a aia i loko o kahi pākēneka nui o nā ʻōpio me kēia maʻi.
ʻO nā kumuhana i lawe i ka fasoracetam ma luna o nā pule he ʻelima o ke aʻo ʻana i hōʻike i ka hoʻomaikaʻi maikaʻi ʻana i nā hana lapaʻau āpau i ka wā o ka hoʻokolokolo. Ua hoʻomau ka emi ʻana o nā hōʻailona ADHD i ka hoʻāʻo ʻana ma hope o ka hoʻāʻo ʻana, a ʻaʻohe o nā mea noiʻi i hōʻike i ka ulu ʻana o ka hoʻomanawanui a i ʻole ka hilinaʻi.
Papakurukama hoʻohana ʻia no ka hoʻomaikaʻi ʻana i ka hana cognitive
Ua ʻike ʻia ʻo Fasoracetam he mea pono ʻole no ka hakakā ʻana i ka hōʻino ʻana i ka hoʻomanaʻo pathological i loaʻa mai nā kūlana e like me ka dementia a i ʻole ka maʻi o Alzheimer. ʻO ka mea maʻamau, ʻaʻole pono ka fasoracetam no ka hoʻolōʻihi ʻana i ka emi ʻana o ka cognitive pili i ka makahiki a no ka hoʻomaikaʻi ʻana i kēlā me kēia ʻano o ka naʻau e pili ana i ka naʻau.
ʻO kēlā'ōlelo, hōʻike nā haʻawina holoholona e hiki ke kūpono i ka fasoracetam no ka hoʻoikaikaʻana i ka hana hoʻomanaʻo. Ma ka haʻawina i haʻi mua ʻia - e ʻike i ka ʻōlelo [1] - ua ʻike nā mea noiʻi ua hiki i ka hoʻokele fasoracetam ke hoʻohuli i ka hōʻino hoʻomanaʻo i hoʻoiho ʻia e ka GABA receptor agonists. Ua hana ʻia kēia haʻawina ma luna o nā rodents, akā ʻo ka hana like i loko o ke kanaka; He mea maʻalahi ka hoʻohaʻahaʻa ʻana i ka hana hoʻokipa GABA (a i ʻole ka hoʻohuli ʻana i nā mea hoʻokipa GABA agnoists) e hoʻomaikaʻi i ka hana hoʻomanaʻo.
Kahi e kūʻai Papakurukama Pauda?
Hōʻike kā mākou loiloi e hōʻike ana ka fasoracetam i ka ʻōlelo hoʻohiki nui no ka mālama ʻana i nā maʻi neurological e like me nā hōʻailona ADHD, autism spectrum disorder, a me ka hopohopo.
Hāʻawi pū ia i nā pōmaikaʻi no ka hoʻomaikaʻi ʻana i nā wahi like ʻole o ka cognition holoʻokoʻa, e like me ka hoʻomaikaʻi ʻana i ka nānā ʻana a me ka noʻonoʻo ʻana, ka hoʻemi ʻana i ka hoʻohaunaele hoʻomanaʻo, a me ka hoʻomaikaʻi ʻana i ka hoʻomanaʻo hoʻomanaʻo, nā mea āpau me ka ʻole o ka hoʻomanawanui a hilinaʻi paha. Hoʻopili kēia i nā ʻōlelo hoʻohiki nootropics maikaʻi no ka hoʻonui ʻana i ka hana o ka lolo.
Raw Fasoracetam Powder Testing Report-HNMR
He aha ka HNMR a He aha ka HNMR spectrum e haʻi aku iā ʻoe? ʻO H Nuclear Magnetic Resonance (NMR) spectroscopy kahi ʻenehana kemika analytical i hoʻohana ʻia i ka hoʻokele maikaʻi a me ka noiʻi no ka hoʻoholo ʻana i ka ʻike a me ka maʻemaʻe o kahi laʻana a me kona ʻano molekala. No ka laʻana, hiki i ka NMR ke hoʻokaʻawale i nā hui pū ʻia i ʻike ʻia. No nā pūhui i ʻike ʻole ʻia, hiki ke hoʻohana ʻia ka NMR e hoʻohālikelike i nā hale waihona puke spectral a i ʻole e kuhi pololei i ke ʻano kumu. Ke ʻike ʻia ke ʻano kumu, hiki ke hoʻohana ʻia ka NMR no ka hoʻoholo ʻana i ka conformation molecular i ka hopena a me ke aʻo ʻana i nā waiwai kino ma ka pae molekala e like me ka hoʻololi conformational, nā hoʻololi ʻana, ka solubility, a me ka diffusion.
Fasoracetam(110958-19-5)-COA
Pehea e kūʻai Papakurukama Pauka mai AASraw?
❶E hoʻokaʻaʻike mai iā mākou ma kā mākou ʻōnaehana nīnau leka uila, a i ʻole e waiho i kāu helu whatsapp iā mākou, e hoʻopili kā mākou mea kūʻai aku (CSR) me ʻoe i loko o 12 mau hola.
❷E hāʻawi mai iā mākou i kāu helu a me kāu helu wahi i nīnau ʻia.
❸Na kā mākou CSR e hāʻawi iā ʻoe i ka ʻōlelo, ka manawa uku, ka helu ʻimi, nā ala hoʻouna a me ka lā i manaʻo ʻia (ETA).
❹E uku ʻia a hoʻouna ʻia nā waiwai i loko o 12 mau hola.
❺ Loaʻa nā waiwai a hāʻawi i nā manaʻo.
Mea kākau o kēia ʻatikala:
Kauka Monique Ua puka 'o Hong mai ke Kula Nui o UK Imperial College London Faculty of Medicine
Mea kākau moʻolelo puke moʻolelo ʻepekema:
1. Bram Harmsen
Institute of Condensed Matter and Nanosciences, Université Catholique de Louvain, Louvain-la-Neuve, Belgium
2. Grace Ungal
Drexel University College of Medicine, Philadelphia, 19129, PA, USA
ʻAʻole ʻae kēia kauka/ ʻepekema i ke kūʻai, kūʻai ʻana, a hoʻohana paha i kēia huahana no kekahi kumu. ʻAʻohe pili a pili ʻole ʻo Aasraw, i hōʻike ʻia a i ʻole, me kēia kauka. ʻO ke kumu o ka haʻi ʻana i kēia kauka, ʻo ia ka hoʻomaikaʻi, hoʻomaikaʻi a hoʻomaikaʻi i ka hana noiʻi a me ka hoʻomohala piha i hana ʻia e nā ʻepekema e hana nei i kēia mea.
Reference
[1] "Fasoracetam i ka poʻe ʻōpio me ADHD a me nā ʻano pūnaewele glutamatergic genes e hoʻopau ana i ka hōʻailona mGluR neurotransmitter". ResearchGate. Loaʻa i ka 2020-10-16.
[2]Malykh, AG; Sadaie, MR (12 Pepeluali 2010). "ʻO nā lāʻau lapaʻau e like me ka piracetam a me ka piracetam: mai ka ʻepekema kumu a hiki i nā noi lapaʻau hou i nā maʻi CNS". ʻO nā lāʻau lapaʻau. 70 (3): 287–312.
[3] Tardner, P. “Fasoracetam ma ke ano he lapaau no ADHD: He loiloi hooponopono o na ikepili lapaau e loaa ana•International Journal of Environmental Science & Technology. Loaʻa i ka 2020-10-16.
[4] "Press Release: Medgenics, Inc. Hoʻolaha i ka hoʻololi inoa iā Aevi Genomic Medicine, Inc". Aevi ma o MarketWired. 16 Kekemapa 2016.
[5]Moskowitz, DH (2017). Ke ʻimi nei i ke kumu Genetic a me Therapy no ADHD, Autism a me 22q. BookBaby (hoʻopuka ponoʻī). ISBN 9781483590981.
